and head-and neck region) (see Figure 1 ).
the filling of hollow organs and peristaltic or more complex changes of the anatomy of patients. If not corrected or compensated for, this variation of the target position may cause imprecise delivery of the irradiation dose with increased doses to the normal tissue and decreased doses to the tumour. Consequences are increased rates of toxicity and decreased tumour control probability. Traditionally, these uncertainties have been compensated for using safety margins around the tumour, which ensure dose coverage of the target volume despite these uncertainties.
However, application of large safety margins increases the delivery of radiation to healthy tissue: this increases the risk of toxicity and limits the total irradiation dose. Recently, image-guided radiotherapy (IGRT) became broadly available. IGRT aims to detect the tumour position immediately prior to treatment, and allows for the adaptation of RT in case the target position changes compared with the planned situation. This more precise delivery of radiation will decrease safety margins, reduce doses to normal tissue and decrease the risk of toxicity, and may allow a safe increase in the radiation dose to improve local tumour control and survival (improvement of the therapeutic ratio). Several randomised trials have confirmed increased rates of biochemical control if irradiation doses were increased from 64 to β to 74 to 79.2Gy. [13] [14] [15] [16] All of the studies used conventional or 3D-conformal RT (3D-CRT) treatment planning techniques and patient set-up was performed according to skin marks and portal imaging, which required rather large safety margins (~10mm). Consequences of large target volumes and suboptimal conformal dose distributions were increased rates of toxicity, especially late rectal toxicity, 17 providing the rationale for the efforts to increase the accuracy of RT.
Precise patient set-up has been reported to be more difficult in obese patients. IGRT-based patient shifts were larger than 10mm in a left-toright direction in 1 and 21% of normal weight and severely obese patients, respectively. 18 This observation of less precise RT could explain reports about decreased biochemical control in obese patients in some, 19, 20 although not all, 21 clinical series, which suggests the particular need for IGRT in this patient cohort.
Clinical Results of Image-guided Radiotherapy
There are no high-evidence-level data showing that IGRT improves outcome in EBRT for prostate cancer; however, promising studies have been reported by several groups. The deleterious effect of a distended rectum in EBRT without IGRT has been described above and two studies demonstrated that IGRT eliminated this 'risk-factor'. 22, 23 Retrospective single-institution studies reported decreased rates of toxicity when IGRT was added to RT, 24, 25 and multiple studies reported low rates of toxicity when IGRT and intensity-modulated radiation therapy (IMRT) were practised in dose-escalated RT (see Figure 2 ).
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Image Guidance for Lung Cancer
Rationale for Image-guided Radiotherapy
Although RT is accepted as the treatment of choice for early-stage non-small-cell lung cancer (NSCLC) in medically inoperable patients, the rates of local tumour control have been disappointing with conventional RT techniques and conventional fractionation (see Figure 3 ). Local failure has been reported in 6-70% of the patients with stage I/II disease, 27 which is substantially higher than the gold standard in medically operable patients using open or video-assisted lobectomy. 28 As a result of the well-established volume effect, 29 local
control is even worse in advanced NSCLC. After simultaneous radiochemotherapy with irradiation doses of 60-66Gy, local tumour control is expected in only one-third of patients. [30] [31] [32] Achieving local tumour control is important even in advanced stages of disease with a high risk of systematic progression. Simultaneous treatment increased locoregional control by an absolute 6%, which transferred into an absolute survival benefit of 6% compared with sequential radiochemotherapy. 33 No difference in systemic progression was observed, indicating that an increase in local control transfers directly to increased overall survival (OS).
Escalation of the irradiation dose beyond 70Gy has been shown to increase local control in both early and advanced-stage NSCLC. 34, 35 However, large safety margins associated with conventional RT planning and delivery techniques do not allow for the safe delivery of such escalated irradiation doses in a substantial proportion of the patients. Improving the accuracy of RT with smaller safety margins is consequently considered to be a safe approach to dose escalation with the potential to increase OS. 
Image Guidance for Intracranial and Head-and-neck Target Volumes
Rationale for Image-guided Radiotherapy 
Clinical Results of Image-guided Radiotherapy
There are limited data on outcomes after image-guided stereotactic RT/radiosurgery. Breneman et al. reported a one-year local control rate of 80% after frameless image-guided radiosurgery of brain metastases, which is similar to results using the frame-based approach. 40 For head-and-neck cancer, IGRT without IMRT has the potential to reduce safety margins. In a prospective study, Den et al. 41 found that daily CBCT for head-and-neck cancer enabled a reduction in the CTV-to-PTV margins by about 50% (except for mobile targets such as the tongue), which could facilitate future studies of dose escalation and/or improved toxicity reduction.
By contrast, IMRT without IGRT is not recommended because the sharp dose gradients in IMRT planning require precise patient set-up.
Consequently, most studies now combine conformal IMRT planning techniques with precise patient set-up using IGRT and preliminary clinical results e.g. in the re-irradiation situation are promising.
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Conclusion
CBCT volume imaging has streamlined and facilitated precision RT. 
